{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T13:01:52Z","timestamp":1791378112063,"version":"4.3.2"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,9,19]],"date-time":"2018-09-19T00:00:00Z","timestamp":1537315200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010977","name":"Vetcare","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100010977","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Veterinary Journal"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.tvjl.2018.08.007","type":"journal-article","created":{"date-parts":[[2018,8,23]],"date-time":"2018-08-23T18:10:00Z","timestamp":1535047800000},"page":"22-26","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Peripherally acting \u03b1-adrenoceptor antagonist MK-467 with intramuscular medetomidine and butorphanol in dogs: A prospective, randomised, clinical trial"],"prefix":"10.1016","volume":"240","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2203-6699","authenticated-orcid":false,"given":"I.J.","family":"Kallio-Kujala","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3025-4805","authenticated-orcid":false,"given":"H.A.","family":"Turunen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.R.","family":"Raekallio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.M.","family":"Honkavaara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.M.","family":"Salla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Casoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1195-5449","authenticated-orcid":false,"given":"H.J.","family":"Hautaj\u00e4rvi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.M.","family":"Vainio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tvjl.2018.08.007_bib0005","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/S0022-3565(25)10402-3","article-title":"Hemodynamic and sedative effects of dexmedetomidine in dog","volume":"263","author":"Bloor","year":"1992","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.tvjl.2018.08.007_bib0010","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S0022-3565(25)22301-1","article-title":"A peripherally acting alpha-2 adrenoceptor antagonist: L-659,066","volume":"245","author":"Clineschmidt","year":"1988","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.tvjl.2018.08.007_bib0015","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1111\/j.1476-5381.1981.tb16793.x","article-title":"Hypotensive and sedative effects of \u03b1-adrenoceptor agonists: relationship to \u03b11- and \u03b12-adrenoceptor potency","volume":"73","author":"Clough","year":"1981","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.tvjl.2018.08.007_bib0020","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1053\/j.tcam.2017.06.002","article-title":"Scaling relationships among heart rate, electrocardiography parameters, and body weight","volume":"32","author":"Cruz Aleixo","year":"2017","journal-title":"Topics in Companion Animal Medicine"},{"key":"10.1016\/j.tvjl.2018.08.007_bib0025","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1111\/vaa.12354","article-title":"Clinical effects and pharmacokinetic variables of romifidine and the peripheral \u03b12-adrenoceptor antagonist MK-467 in horses","volume":"43","author":"DeVries","year":"2016","journal-title":"Veterinary Anaesthesia and Analgesia"},{"key":"10.1016\/j.tvjl.2018.08.007_bib0030","doi-asserted-by":"crossref","first-page":"728","DOI":"10.2460\/ajvr.69.6.728","article-title":"Effects of a peripheral \u03b12 adrenergic-receptor antagonist on the hemodynamic changes induced by medetomidine administration in conscious dogs","volume":"69","author":"Enouri","year":"2008","journal-title":"American Journal of Veterinary Research"},{"key":"10.1016\/j.tvjl.2018.08.007_bib0035","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1136\/vr.129.10.213","article-title":"Ambulatory electrocardiography in dogs","volume":"129","author":"Hall","year":"1991","journal-title":"Veterinary Record"},{"key":"10.1016\/j.tvjl.2018.08.007_bib0040","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/j.1467-2995.2008.00403.x","article-title":"The effects of L-659,066, a peripheral \u03b12-adrenoceptor antagonist, on dexmedetomidine induced sedation and bradycardia in dogs","volume":"35","author":"Honkavaara","year":"2008","journal-title":"Veterinary Anaesthesia and Analgesia"},{"key":"10.1016\/j.tvjl.2018.08.007_bib0045","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1111\/j.1365-2885.2010.01242.x","article-title":"The effects of increasing doses of MK-467, a peripheral alpha2-adrenergic receptor antagonist, on the cardiopulmonary effects of intravenous dexmedetomidine in conscious dogs","volume":"34","author":"Honkavaara","year":"2011","journal-title":"Journal of Veterinary Pharmacology and Therapeutics"},{"key":"10.1016\/j.tvjl.2018.08.007_bib0050","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1007\/BF00500476","article-title":"Regional variation in the alpha-adrenergic receptors in the canine resistance vessels","volume":"318","author":"Horn","year":"1982","journal-title":"Naunyn-Schmiedeberg\u2019s Archives of Pharmacology"},{"key":"10.1016\/j.tvjl.2018.08.007_bib0055","series-title":"Proceedings of the Association of Veterinary Anesthetists","first-page":"74","article-title":"MK-467 accelerates the absorption of sedative agents in dogs\u2014preliminary results","author":"Kallio-Kujala","year":"2017"},{"key":"10.1016\/j.tvjl.2018.08.007_bib0060","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.2460\/javma.2000.216.1578","article-title":"Sedative and cardiorespiratory effects of medetomidine, medetomidinebutorphanol and medetomidine\u2013ketamine in dogs","volume":"216","author":"Ko","year":"2000","journal-title":"Journal of the American Veterinary Medical Association"},{"key":"10.1016\/j.tvjl.2018.08.007_bib0065","doi-asserted-by":"crossref","first-page":"931","DOI":"10.2460\/ajvr.2004.65.931","article-title":"Comparative cardiovascular, analgesic, and sedative effects of medetomidine, medetomidine\u2013hydromorphone, and medetomidinebutorphanol in dogs","volume":"65","author":"Kuo","year":"2004","journal-title":"American Journal of Veterinary Research"},{"key":"10.1016\/j.tvjl.2018.08.007_bib0070","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/j.1365-2885.1994.tb00225.x","article-title":"Effects of medetomidine on intestinal and colonic motility in the dog","volume":"17","author":"Maugeri","year":"1994","journal-title":"Journal of Veterinary Pharmacology and Therapeutics"},{"key":"10.1016\/j.tvjl.2018.08.007_bib0075","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.1467-2995.2005.00233.x","article-title":"Medetomidine and dexemedtomidine: a review of cardiovascular effects and analgesic properties in the dog","volume":"32","author":"Murrell","year":"2005","journal-title":"Veterinary Anaesthesia and Analgesia"},{"key":"10.1016\/j.tvjl.2018.08.007_bib0080","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1111\/j.1440-1681.2004.04081.x","article-title":"Circadian changes in the QT variability index in the beagle dog","volume":"31","author":"Nolan","year":"2004","journal-title":"Clinical and Experimental Pharmacology and Physiology"},{"key":"10.1016\/j.tvjl.2018.08.007_bib0085","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S1053-0770(98)90197-5","article-title":"A novel alpha2-adrenoceptor antagonist attenuates the early, but preserves the late cardiovascular effects of intravenous dexmedetomidine in conscious dogs","volume":"12","author":"Pagel","year":"1998","journal-title":"Journal of Cardiothoracic and Vascular Anesthesia"},{"key":"10.1016\/j.tvjl.2018.08.007_bib0090","doi-asserted-by":"crossref","first-page":"724","DOI":"10.2460\/ajvr.1996.57.05.724","article-title":"Hemodynamic effects of medetomidine\u2013midazolam\u2013butorphanol and medetomidine\u2013midazolam\u2013buprenorphine combinations and reversibility by atipamezole in dogs","volume":"57","author":"Pypendop","year":"1996","journal-title":"American Journal of Veterinary Research"},{"key":"10.1016\/j.tvjl.2018.08.007_bib0095","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1111\/j.1532-950X.1998.tb00539.x","article-title":"Hemodynamic effects of medetomidine in the dog: a dose titration study","volume":"27","author":"Pypendop","year":"1998","journal-title":"Veterinary Surgery"},{"key":"10.1016\/j.tvjl.2018.08.007_bib0100","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1111\/vaa.12276","article-title":"Indexing cardiovascular and respiratory variables: allometric scaling principles","volume":"42","author":"Pypendop","year":"2015","journal-title":"Veterinary Anaesthesia and Analgesia"},{"key":"10.1016\/j.tvjl.2018.08.007_bib0105","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/j.1467-2995.2011.00630.x","article-title":"Effects of different doses of L-659\u2019066 on the bispectral index and clinical sedation in dogs treated with dexmedetomidine","volume":"38","author":"Restitutti","year":"2011","journal-title":"Veterinary Anaesthesia and Analgesia"},{"key":"10.1016\/j.tvjl.2018.08.007_bib0110","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.vaa.2016.04.006","article-title":"Plasma concentration, cardiovascular and sedative effects of intramuscular medetomidine with three doses of the peripheral alpha2 antagonist MK-467 in dogs","volume":"44","author":"Restitutti","year":"2017","journal-title":"Veterinary Anaesthesia and Analgesia"},{"key":"10.1016\/j.tvjl.2018.08.007_bib0115","first-page":"47","article-title":"Cardiovascular actions of detomidine","volume":"82","author":"Savola","year":"1986","journal-title":"Acta Veterinaria Scandinavica"},{"key":"10.1016\/j.tvjl.2018.08.007_bib0120","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1111\/vaa.12158","article-title":"The cardiopulmonary effects of a peripheral alpha-2-adrenoceptor antagonist, MK-467, in dogs sedated with a combination of medetomidine and butorphanol","volume":"41","author":"Salla","year":"2014","journal-title":"Veterinary Anaesthesia and Analgesia"},{"key":"10.1016\/j.tvjl.2018.08.007_bib0125","first-page":"11","article-title":"An introduction to the pharmacology of alpha 2-adrenoceptors in the central nervous system","volume":"85","author":"Scheinin","year":"1989","journal-title":"Acta Veterinaria Scandinavica Supplementum"},{"key":"10.1016\/j.tvjl.2018.08.007_bib0130","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/cphy.c110049","article-title":"Metabolic scaling in animals: methods, empirical results, and theoretical explanations","volume":"4","author":"White","year":"2014","journal-title":"Comparative Physiology"}],"container-title":["The Veterinary Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1090023318304805?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1090023318304805?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,6]],"date-time":"2025-07-06T14:14:34Z","timestamp":1751811274000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1090023318304805"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":26,"alternative-id":["S1090023318304805"],"URL":"https:\/\/doi.org\/10.1016\/j.tvjl.2018.08.007","relation":{},"ISSN":["1090-0233"],"issn-type":[{"value":"1090-0233","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Peripherally acting \u03b1-adrenoceptor antagonist MK-467 with intramuscular medetomidine and butorphanol in dogs: A prospective, randomised, clinical trial","name":"articletitle","label":"Article Title"},{"value":"The Veterinary Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tvjl.2018.08.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}